MedPath

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Phase 3
Completed
Conditions
Psoriasis
Interventions
Registration Number
NCT01908595
Lead Sponsor
Maruho North America Inc.
Brief Summary

This study is to evaluate the efficacy and safety for long term use of M518101 in subjects with plaque psoriasis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
480
Inclusion Criteria
  • Who are able and willing to give signed informed consent
  • Who are male or females aged 18 years or older with plaque psoriasis confirmed by the Investigator.
  • Who have up to 20% of body surface area (BSA) afflicted with plaques
  • Who are neither pregnant nor breast-feeding, nor plan to become pregnant during the study.
Exclusion Criteria
  • Who have a history of allergy to vitamin D3 derivative preparations or a history of relevant drug hypersensitivity.
  • Who are pregnant or lactating.
  • Who have any renal or hepatic insufficiency, or clinically significant cardiac, renal or hepatic disease.
  • Who are not deemed eligible as determined by medical history, physical examination or clinical laboratory safety tests.
  • Who have clinically relevant history or presence of any disease or surgical history other than psoriasis which is likely to affect the conduct of the study.
  • Whose serum calcium levels exceed the upper limit of reference range
  • Who have used any investigational medicinal product and/or participated in any clinical study within 60 days of treatment.
  • Who have been treated with systemic therapy within 30days of treatment.
  • Who have treated with biologics within 5 half-lives of the biologics before the day of treatment
  • Who have been treated with topical therapy within 14days before the day of treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
M518101M518101Proper quantity twice daily
Primary Outcome Measures
NameTimeMethod
Time course change of Investigator Global Assessment4 weeks interval
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (31)

Medical Center for Clinical Research

🇺🇸

San Diego, California, United States

Dermatology and Aesthetic Center Skin Care

🇺🇸

Boca Raton, Florida, United States

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

Peachtree Dermatology Associates Research Center

🇺🇸

Atlanta, Georgia, United States

Northshore University Health System

🇺🇸

Skokie, Illinois, United States

PMG Research of Bristol

🇺🇸

Kingsport, Tennessee, United States

Dermatology Associates of Knoxville

🇺🇸

Knoxville, Tennessee, United States

Horizons Clinical Research Center

🇺🇸

Denver, Colorado, United States

Bakersfield Dermatology and Skin Cancer Medical Group

🇺🇸

Bakersfield, California, United States

FXM Research Miramar

🇺🇸

Miramar, Florida, United States

Suzanne Bruce & Associates

🇺🇸

Houston, Texas, United States

USF Health Morsani Center for Advanced Healthcare

🇺🇸

Tampa, Florida, United States

Bager Allergy, Asthma and Dermatology Research Center

🇺🇸

Lake Oswego, Oregon, United States

Dermatology Research Associates

🇺🇸

Los Angeles, California, United States

Agave Clinical Research

🇺🇸

Mesa, Arizona, United States

ATS Clinical Research

🇺🇸

Santa Monica, California, United States

Jacksonville Center for Clinical Research

🇺🇸

Jacksonville, Florida, United States

PMG research of raleigh

🇺🇸

Cary, North Carolina, United States

Minnesota Clinical Study Center

🇺🇸

Fridley, Minnesota, United States

Progressive Clinical Research

🇺🇸

San Antonio, Texas, United States

Stephen Miller

🇺🇸

San Antonio, Texas, United States

J Woodson Dermatology and Associates

🇺🇸

Henderson, Nevada, United States

PMG Research of Wilmington

🇺🇸

Wilmington, North Carolina, United States

South bend clinic

🇺🇸

South Bend, Indiana, United States

New York University

🇺🇸

New York, New York, United States

Madison Skin & Research

🇺🇸

Madison, Wisconsin, United States

Dermatology Research Center

🇺🇸

Salt Lake City, Utah, United States

Research Across America

🇺🇸

Plano, Texas, United States

Kansas City Dermatology

🇺🇸

Overland Park, Kansas, United States

The skin wellness center

🇺🇸

Knoxville, Tennessee, United States

Radiant Research

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath